Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VV3O
|
|||
| Former ID |
DIB001355
|
|||
| Drug Name |
GNI-104
|
|||
| Synonyms |
Ed-004; Neutralizing monoclonal antibodies (HCV), Innogenetics
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Terminated | [1] | |
| Company |
GENimmune NV
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis C virus Envelope glycoprotein (HCV Env) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027514) | |||
| REF 2 | WO patent application no. 2009,1433,45, Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.